135 related articles for article (PubMed ID: 2919489)
1. Remarkable effect of endocrine therapy on brain metastasis from prostatic carcinoma.
Senoh H; Ichikawa Y; Matsuda M; Iwatsubo H; Kumahara Y; Sagawa S
Urology; 1989 Mar; 33(3):243-6. PubMed ID: 2919489
[TBL] [Abstract][Full Text] [Related]
2. [Predictive value of clinical, biochemical, hormonal and histologic parameters of the endocrine response in prostatic adenocarcinoma].
Burgos FJ; Maganto E; Jiménez M; Mayayo T; Allona A; Mateos A; Escudero A; Romero-Aguirre C
Actas Urol Esp; 1988; 12(6):500-6. PubMed ID: 3232555
[No Abstract] [Full Text] [Related]
3. Effect of endocrine therapy on a brain metastatic lesion of prostatic carcinoma.
Kohri K; Yamate T; Tsujihashi H; Nakao Y; Katayama Y; Hara Y; Morikawa Y; Kurita T
Urol Int; 1991; 47(2):100-2. PubMed ID: 1792703
[TBL] [Abstract][Full Text] [Related]
4. Effects of diethylstilbestrol and estramustine phosphate on serum sex hormone binding globulin and testosterone levels in prostate cancer patients.
Karr JP; Wajsman Z; Kirdani RY; Murphy GP; Sandberg AA
J Urol; 1980 Aug; 124(2):232-6. PubMed ID: 7190620
[TBL] [Abstract][Full Text] [Related]
5. [Prostatic cancer presenting as palpable lymph node metastasis--report of three cases].
Masuda H; Yamada T; Nagahama K; Nagamatsu H; Negishi T
Hinyokika Kiyo; 1992 Nov; 38(11):1269-72. PubMed ID: 1485580
[TBL] [Abstract][Full Text] [Related]
6. Metastases to the penis from carcinoma of the prostate. A case report.
Smehaug J
Scand J Urol Nephrol; 1979; 13(2):205-6. PubMed ID: 482872
[TBL] [Abstract][Full Text] [Related]
7. [A case of advanced prostatic cancer in a 44-year-old treated effectively with combination chemo-endocrine therapy].
Araki S; Kusuyama H; Kato M; Okada K
Hinyokika Kiyo; 1990 Apr; 36(4):465-9. PubMed ID: 1696064
[TBL] [Abstract][Full Text] [Related]
8. Estramustine phosphate versus stilbestrol as primary treatment for metastatic cancer of the prostate.
Nickel CJ; Morales A
Can J Surg; 1983 Sep; 26(5):434-8. PubMed ID: 6351988
[TBL] [Abstract][Full Text] [Related]
9. A comparison of the effect of diethylstilbestrol with low dose estramustine phosphate in the treatment of advanced prostatic cancer: final analysis of a phase III trial of the European Organization for Research on Treatment of Cancer.
Smith PH; Suciu S; Robinson MR; Richards B; Bastable JR; Glashan RW; Bouffioux C; Lardennois B; Williams RE; de Pauw M
J Urol; 1986 Sep; 136(3):619-23. PubMed ID: 3525866
[TBL] [Abstract][Full Text] [Related]
10. Results of another trial of chemotherapy with and without hormones in patients with newly diagnosed metastatic prostate cancer.
Murphy GP; Huben RP; Priore R
Urology; 1986 Jul; 28(1):36-40. PubMed ID: 3523938
[TBL] [Abstract][Full Text] [Related]
11. [Hormonal treatment of cancer of the prostate].
Aguiló F; Torrecilla C; Muñoz J; Tesedo X; Vigués F; Serrallach N
Actas Urol Esp; 1989; 13(4):256-63. PubMed ID: 2678937
[TBL] [Abstract][Full Text] [Related]
12. [Effective hormone therapy of prostatic cancer with lung metastasis: 2 cases].
Miyabe N; Maeno K; Enami N; Harada H; Kawakura K
Hinyokika Kiyo; 1989 May; 35(5):901-4. PubMed ID: 2801385
[TBL] [Abstract][Full Text] [Related]
13. Effect of endocrine treatment on prostatic blood flow in patients with prostatic adenocarcinoma.
Toma H; Nakamura R; Onitsuka S; Goya N; Nakazawa H
J Urol; 1988 Jul; 140(1):91-5. PubMed ID: 3132563
[TBL] [Abstract][Full Text] [Related]
14. [Brain metastases from colorectal cancer].
Vagn-Hansen CA; Rafaelsen SR
Ugeskr Laeger; 2001 Mar; 163(13):1864-5. PubMed ID: 11293317
[TBL] [Abstract][Full Text] [Related]
15. A randomized double blind crossover trial of diethylstilbestrol (DES) and estramustine phosphate (Emcyt) for stage D prostatic carcinoma.
Benson RC; Gill GM; Cummings KB
Semin Oncol; 1983 Sep; 10(3 Suppl 3):43-5. PubMed ID: 6364366
[No Abstract] [Full Text] [Related]
16. [Chemoendocrine therapy of newly diagnosed advanced prostatic cancer].
Numasawa K; Kubota Y; Suzuki H; Kakizaki H; Takamizawa A; Saito M; Suzuki K; Kato H; Hirano J; Hirano K
Nihon Hinyokika Gakkai Zasshi; 1989 Jan; 80(1):39-47. PubMed ID: 2724744
[TBL] [Abstract][Full Text] [Related]
17. Effect of treatment with diethylstilbestrol-polyestradiol phosphate or estramustine phosphate (estracyt) on natural killer cell activity in patients with prostatic cancer.
Kalland T; Haukaas S
Invest Urol; 1981 May; 18(8):437-9. PubMed ID: 7228576
[TBL] [Abstract][Full Text] [Related]
18. [Prostate cancer with penile metastasis: a case report].
Sawada A; Segawa T; Nakanishi S; Kinoshita H; Yamamoto S; Kamoto T; Ogawa O
Hinyokika Kiyo; 2005 Nov; 51(11):771-3. PubMed ID: 16363713
[TBL] [Abstract][Full Text] [Related]
19. Estramustine affects bone mineral metabolism in metastatic prostate cancer.
Citrin DL; Wallemark CB; Nadler R; Geiger C; Tuttle K; Kaplan EH; Hauck W
Cancer; 1986 Nov; 58(10):2208-13. PubMed ID: 3756769
[TBL] [Abstract][Full Text] [Related]
20. [Hormonal treatment of carcinoma of the prostate].
Obata K; Kobayashi H; Murase T; Ohisi M
Hinyokika Kiyo; 1991 Aug; 37(8):809-16. PubMed ID: 1720272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
